Invention Grant
US09326936B2 Aerosol fluoroquinolone formulations for improved pharmacokinetics
有权
气雾剂氟喹诺酮配方，用于改善药代动力学
- Patent Title: Aerosol fluoroquinolone formulations for improved pharmacokinetics
- Patent Title (中): 气雾剂氟喹诺酮配方，用于改善药代动力学
-
Application No.: US14333583Application Date: 2014-07-17
-
Publication No.: US09326936B2Publication Date: 2016-05-03
- Inventor: David C. Griffith , Michael N. Dudley , Mark W. Surber , Keith A. Bostian , Olga Rodny
- Applicant: Raptor Pharmaceuticals Inc.
- Applicant Address: US CA Novato
- Assignee: Raptor Pharmaceuticals, Inc.
- Current Assignee: Raptor Pharmaceuticals, Inc.
- Current Assignee Address: US CA Novato
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: A61K31/397
- IPC: A61K31/397 ; A61K31/535 ; A61P11/06 ; A61K9/00 ; A61K31/4375 ; A61K31/47 ; A61K31/538 ; A61K47/02 ; A61K31/536
Abstract:
The present invention relates to the field of antimicrobial agents. In particular, the present invention relates to the use of aerosolized fluoroquinolones formulated with divalent or trivalent cations and having improved pulmonary availability for the treatment and management of bacterial infections of the lung and upper respiratory tract.
Public/Granted literature
- US20140329810A1 AEROSOL FLUOROQUINOLONE FORMULATIONS FOR IMPROVED PHARMACOKINETICS Public/Granted day:2014-11-06
Information query
